Insert the needle into the center of this fold at a 90-degree angle, or at a 45-degree angle if the fold is thin
Originally developed as an injectable diabetes medication, Tirzepatide has shown remarkable efficacy in addressing weight-related health challenges, including insulin resistance and metabolic syndrome
Tirzepatide is revolutionizing weight loss and type 2 diabetes management by offering a dual-action approach targeting both GLP-1 and GIP receptors
No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred
Among people who were prescribed a GLP-1 medication for weight loss such as semaglutide (branded as Ozempic and Wegovy), exenatide (Byetta) and liraglutide (Victoza) 10 out of every 10,000, or 0.1%, were diagnosed with gastroparesis at least six months later